Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Merck
Colorcon
Julphar
Deloitte
Boehringer Ingelheim
Dow
US Army
Federal Trade Commission

Generated: May 25, 2018

DrugPatentWatch Database Preview

NICOTINE POLACRILEX - Generic Drug Details

or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for nicotine polacrilex and what is the scope of nicotine polacrilex freedom to operate?

Nicotine polacrilex
is the generic ingredient in four branded drugs marketed by Glaxosmithkline, Actavis Labs Ny Inc, Ivax Sub Teva Pharms, L Perrigo Co, Perrigo R And D, Watson Labs, and Glaxosmithkline Cons, and is included in forty NDAs. There are three patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Nicotine polacrilex has forty patent family members in twenty countries.

There are thirty drug master file entries for nicotine polacrilex. Forty-three suppliers are listed for this compound.
Summary for NICOTINE POLACRILEX
Synonyms for NICOTINE POLACRILEX
(-)-.beta.-Pyridyl-.alpha.-N-methylpyrrolidine
(-)-1-(1/4)x>>u-2-(3-ssAa currency>>u)ssA inverted question mark(c)Ie
(-)-1-Methyl-2-(3-pyridyl)pyrrolidine, 3 Pyrid-N-methylpyrrolidin
(-)-3-(1-Methyl-2-pyrrolidyl)pyridine
(-)-3-(N-Methylpyrrolidino)pyridine
(-)-Nicotine
(-)-Nicotine solution
(-)-Nicotine solution, 1.0 mg/mL, analytical standard, for drug analysis
(-)-Nicotine solution, 100 mug/mL in acetonitrile, PESTANAL(R), analytical standard
(-)-Nicotine, >=99% (GC), liquid
(-)-Nicotine, PESTANAL(R), analytical standard
(-)-Nicotine;(S)-Nicotine
(2S) 3-(1-Methyl-pyrrolidin-2-yl)-pyridine
(S)-(-)--nicotine
(S)-(-)-Nicotine
(S)-(-)-NICOTINE, 3-[(2S)-1-METHYL-2-PYRROLIDINYL] PYRIDINE
(S)-(-)-Nicotine, 99% 25g
(S)-3-(1-Methyl-2-pyrrolidinyl)pyridine
(S)-3-(1-methylpyrrolidin-2-yl)pyridine
(S)-3-(N-methylpyrrolidin-2-yl)pyridine
(S)-Nicotine
006N369
1-methyl-2-(3-pyridal)-pyrrolidene
1-methyl-2-(3-pyridal)-Pyrrolidine
1-Methyl-2-(3-pyridiyl)pyrrolidine
1-Methyl-2-(3-pyridyl)pyrrolidine
13890-81-8
13890-82-9
16760-37-5
1uw6
3-((2S)-1-methylpyrrolidin-2-yl)pyridine
3-(1-Methyl-2-pyrollidinyl)pyridine
3-(1-methyl-2-pyrrolidinyl)-Pyridine
3-(1-Methyl-2-pyrrolidinyl)pyridine
3-(2-(N-methylpyrrolidinyl))pyridine
3-(N-Methylpyrollidino)pyridine
3-(N-Methylpyrrolidino)pyridine
3-[(1R)-1beta-Methylpyrrolidine-2alpha-yl]pyridine
3-[(2S)-1-methylpyrrolidin-2-yl]pyridine
3-N-methylpyrrolidine
434F7990-3240-4A43-ACEC-E6CC1E495FA0
54-11-5
551-13-3
6912-85-2
6M3C89ZY6R
a -N-methylpyrrolidine
a-N-methylpyrrolidine
AB00694322_12
AC1L3I79
AC1Q3ZOC
AI3-03424
AJ-21117
AK114679
alpha-N-methylpyrrolidine
AN-24414
BB_NC-0777
BDBM82070
beta-Pyridyl-alpha-N-methyl pyrrolidine
beta-Pyridyl-alpha-N-methylpyrrolidine
BIDD:GT0599
Black leaf
bmse000105
BRD-K05395900-322-02-1
C00745
Campbell's nico-soap
CAS_29790-52-1
CAS-54-11-5
Caswell No. 597
CCG-204892
CCRIS 1637
CHEBI:17688
CHEMBL3
CPD000059074
CS-3999
CTK8F2098
D03365
D05QIM
D0T8GD
DB00184
delta-Nicotine
destruxol
Destruxol orchid spray
DL-tetrahydronicotyrine
DSSTox_CID_930
DSSTox_GSID_20930
DSSTox_RID_75874
DTXSID1020930
EC 200-193-3
EINECS 200-193-3
Emo-nik
ENT 3,424
EPA Pesticide Chemical Code 056702
Exodus
Flux MAAG
FT-0603228
FT-0672702
fumeto bac
Fumetobac
GTPL2585
Habitrol
Habitrol (TN)
HE001276
HE350412
HMS2230H17
HMS3259E16
HSDB 1107
HY-B0638
I14-111388
J-500021
L-3-(1-Methyl-2-pyrrolidyl)pyridine
L-Nicotine
L(-)-nicotine
Mach-Nic
MCULE-8728421654
methyl-2-pyrrolidinyl)pyridine
MFCD00006369
Micotine
MLS001055457
MLS001335905
MolPort-000-744-731
N0079
NC00577
NCGC00090693-01
NCGC00090693-02
NCGC00090693-03
NCGC00090693-04
NCGC00090693-05
NCGC00090693-06
NCGC00090693-07
NCGC00090693-08
NCGC00090693-09
NCGC00254095-01
NCGC00259363-01
NCT
Niagara P.A. dust
Nic-Sal
Nicabate
Nico-dust
Nico-Fume
Nicocide
Nicoderm
Nicoderm Cq
Nicoderm Patch
Nicorette
Nicorette (TN)
Nicorette, Nicotrol
Nicotin
Nicotina
Nicotina [Italian]
nicotine
Nicotine (compounds related to)
Nicotine (USP)
Nicotine [BSI:ISO]
Nicotine [for single use]
Nicotine [UN1654]
Nicotine [UN1654] [Poison]
Nicotine [UN1654] [Poison]
Nicotine [USAN]
Nicotine [USP:BAN]
Nicotine 10 microg/mL in Methanol
Nicotine 100 microg/mL in Methanol
Nicotine abuse therapy, ImmuLogic
Nicotine alkaloid
NICOTINE AND SALTS
Nicotine betadex
nicotine bitartrate anhydrous
Nicotine Difartrate
Nicotine Patch
Nicotine polacrilex [USAN]
nicotine replacement patch
Nicotine solution
Nicotine vaccine, Xenova
Nicotine-D salicylate
NICOTINE-L (BASE)
Nicotinum
Nicotrol
Nicotrol Inhaler
Nicotrol NS
Nictoine patch
Nikotin [German]
Nikotyna
Nikotyna [Polish]
Niquitin
NSC 5065
Ortho N-4 and N-5 dusts
Ortho N-4 dust
Ortho N-5 dust
PDSP1_000113
PDSP1_000465
PDSP2_000463
PDSP2_000555
Prostep
Pyridine, 3-((2S)-1-methyl-2-pyrrolidinyl)-
Pyridine, 3-(1-methyl-2-pyrrolidinyl)-, (S)-
Pyridine, 3-(1-methyl-2-pyrrolidinyl)-, (S)- (9CI)
Pyridine, 3-(tetrahydro-1-methylpyrrol-2-yl)
Pyridine, 3-(tetrahydro-1-methylpyrrol-2-yl), (S)-
Pyrrolidine, 1-methyl-2-(3-pyridal)-
Pyrrolidine, 1-methyl-2-(3-pyridyl)-
R)-(+)-nicotine
RCRA waste no. P075
RCRA waste number P075
S-(-)-Nicotine
S-()-Nicotine-pyridine-d4
S(-)-Nicotine solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material
SAM002564224
SBB012359
SBI-0050785.P003
SC-58411
SCHEMBL20192
SDCCGMLS-0066911.P001
SMR000059074
SNICXCGAKADSCV-JTQLQIEISA-N
SR-05000001762
SR-05000001762-5
ST069320
TA-NIC
Tabazur
Tendust
Tetrahydronicotyrine, DL-
Tox21_201814
Tox21_300174
Transdermal Nicotine
UN1654
UNII-6M3C89ZY6R
Vaccine (nicotine), Xenova
XL All Insecticide
Z1954805269
ZINC391812

US Patents and Regulatory Information for NICOTINE POLACRILEX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Labs Ny Inc NICOTINE POLACRILEX nicotine polacrilex GUM, CHEWING;BUCCAL 076568-002 Jul 29, 2004 OTC No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Glaxosmithkline NICORETTE (MINT) nicotine polacrilex GUM, CHEWING;BUCCAL 018612-003 Dec 23, 1998 OTC Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Perrigo R And D NICOTINE POLACRILEX nicotine polacrilex GUM, CHEWING;BUCCAL 091349-001 Jul 20, 2011 OTC No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Glaxosmithkline Cons THRIVE nicotine polacrilex GUM, CHEWING;BUCCAL 077656-001 Jun 19, 2007 OTC No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

Expired US Patents for NICOTINE POLACRILEX

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Glaxosmithkline Cons NICORETTE nicotine polacrilex TROCHE/LOZENGE;ORAL 021330-001 Oct 31, 2002 ➤ Try a Free Trial ➤ Try a Free Trial
Glaxosmithkline Cons NICORETTE nicotine polacrilex TROCHE/LOZENGE;ORAL 022360-002 May 18, 2009 ➤ Try a Free Trial ➤ Try a Free Trial
Glaxosmithkline Cons NICORETTE nicotine polacrilex TROCHE/LOZENGE;ORAL 021330-002 Oct 31, 2002 ➤ Try a Free Trial ➤ Try a Free Trial
Glaxosmithkline Cons NICORETTE nicotine polacrilex TROCHE/LOZENGE;ORAL 022360-001 May 18, 2009 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents for NICOTINE POLACRILEX

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,658,200 Flavoring of drug-containing chewing gums ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Cipla
Federal Trade Commission
Queensland Health
Moodys
Deloitte
Covington
Daiichi Sankyo
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.